Browse by portfolio

Curated collections of public companies.

NYSE-Listed

425 companies

OTCMKTS-Listed

25 companies

Latest Headlines

Follow companies to personalize your feed

Today

Reliance Global Group, Inc.Business

Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA’s Biotech Division

10 minutes ago

Whirlpool CorporationU.S.

Whirlpool Foundation Announces 2026 Sons & Daughters Scholarship Recipients

10 minutes ago

Caci International, Inc.Business

CACI Appoints Christopher Monoski as Executive Vice President, Manufacturing

10 minutes ago

Parsons CorporationTechnology

EVERYWHERE Communications Partners with Parsons to Enable Resilient, Beyond-Line-of-Sight Autonomous Drone Operations Under SBIR Initiative

11 minutes ago

Adeia Inc.Business

L’Oréal and Adeia Enter Multi-Year License Agreement

11 minutes ago

Guardant Health, Inc.Business

Guardant Health Receives FDA Approval for Guardant360® CDx as a Companion Diagnostic for Arvinas and Pfizer’s VEPPANU (vepdegestrant) for Patients with ER+/HER2- Advanced Breast Cancer with ESR1 Mutations

11 minutes ago

Candel Therapeutics, Inc.Business

Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting

11 minutes ago

Safe Pro Group Inc.Business

Safe Pro Launches New Growth Team Led by Brian Mack as Chief Growth Officer and Benjamin Chitty as VP of Government Growth

11 minutes ago

Alto Neuroscience, Inc.Business

Alto Neuroscience Presents Phase 2a Data for ALTO-207 in Major Depressive Disorder at SOBP Annual Meeting

12 minutes ago

Xencor, Inc.Business

Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW

12 minutes ago

Johnson & JohnsonHealth

CAPLYTA® (lumateperone) showed greatest improvement across key efficacy outcomes among adjunctive MDD treatments in new network meta-analysis

12 minutes ago

Easterly Government Properties, Inc.Business

Easterly Government Properties to Participate in Wells Fargo 29th Annual Real Estate Securities Conference

13 minutes ago

Akebia Therapeutics, Inc.Health

Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology

13 minutes ago

Boston Scientific CorporationBusiness

Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results

13 minutes ago

Hess Midstream LpBusiness

Hess Midstream LP Reports Estimated Results for the First Quarter of 2026

13 minutes ago

Ncr Voyix CorporationBusiness

Stater Bros. Markets Signs New Agreement With NCR Voyix to Modernize POS and Payments on the Voyix Commerce Platform

13 minutes ago

Ruanyun Edai Technology Inc.Business

Ruanyun Edai Technology’s Saudi RHQ Signs MOU with Wadi Makkah, A Subsidiary of Umm Al-Qura University

14 minutes ago

Trinity Capital Inc.Business

Trinity Capital Receives SBIC License from US SBA

14 minutes ago

Wheels Up Experience Inc.Business

Wheels Up Announces Date of First Quarter 2026 Earnings Release

14 minutes ago

Lobo Technologies Ltd.Business

LOBO Claw AI Agent Completes New Round of Upgrades with DeepSeek V4 Model Integration

14 minutes ago

Business

Jan 20 2023

5 min read

Press Release Jan 20 2023

Name: 6ix Investment Platform
Brand: 6ix

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 20, 2023, titled "Dr. Reddy s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe".

View Attachment